Amgen Said to Boost Bid for Onyx to $130 a Share

Aug. 6 (Bloomberg) -- Amgen, the drugmaker in pursuit of Onyx Pharmaceuticals, boosted its offer for the company to $130 a share, according to a person familiar with the matter. Olivia Sterns reports on Bloomberg Television's "Street Smart." (Source: Bloomberg)
Japan's Nishimura Speaks About Abenomics, Economy
31:45 - Japan's Deputy Economy Minister Yasutoshi Nishimura talks about the impact of the government's fiscal and monetary policy on the country's economy. Bloomberg's Brian Fowler moderates the discussion in New York. (Nishimura's remarks in Japanese are translated into English. Source: Bloomberg)
  • Milagro's Recipe for Great Tequila
  • Why Herbalife Shares Are Surging Despite Regulatory Probe
  • Find Out How Jose Cuervo Is Aged and Processed